LYOCELL
Dead / Cancelled — Cancelled — Section 8 (as of 24 Oct 2014)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 76373277
- Registration number
- 2824420
- Mark type
- Word mark
- Filed
- 22 Feb 2002
- Published for opposition
- 30 Dec 2003
- Registered
- 23 Mar 2004
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations consisting of nano and micro particles that contain bioactive agents and utilize lyotropic liquids and liquid crystals, and ingredients and components thereof for use in prevention and treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, circulatory system and blood, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central, peripheral, autonomous, sympathetic and parasympathetic nervous system, diseases or conditions of the muscle and motor system, diseases and conditions of the skeletal system and bone, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders, hormonal disorders, protein disorders, genetic disorders, immune system, and gynecological conditions; for use in the alleviation or prevention or suppression of pain and the administration of anesthesia, antipyretics, and anti-inflammatory agents, veterinary preparations consisting of nano and micro particles containing bioactive agents and utilize lyotropic liquids and liquid crystals, and ingredients and components thereof for use in prevention and treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, circulatory system and blood, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central, peripheral, autonomous, sympathetic and parasympathetic nervous system, diseases or conditions of the muscle and motor system, diseases and conditions of the skeletal system and bone, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders, hormonal disorders, protein disorders, genetic disorders, immune system, and gynecological conditions; for use in the alleviation or prevention or suppression of pain and the administration of anesthesia, antipyretics and anti-inflammatory agents
Owner
- Lyotropic Therapeutics, Inc., Ashland, VA, US
- Lyotropic Therapeutics, Inc., Ashland, VA, US
- Lyotropic Therapeutics, Inc., Ashland, VA, US
Prosecution history
- 24 Oct 2014 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 14 May 2013 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 31 Mar 2010 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 31 Mar 2010 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Mar 2010 — TEAS SECTION 8 & 15 RECEIVED
- 23 Mar 2004 — REGISTERED-PRINCIPAL REGISTER
- 30 Dec 2003 — PUBLISHED FOR OPPOSITION
- 10 Dec 2003 — NOTICE OF PUBLICATION
- 15 Sept 2003 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Aug 2003 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Aug 2003 — PAPER RECEIVED
- 20 Aug 2003 — PAPER RECEIVED
- 19 Aug 2003 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Aug 2003 — CASE FILE IN TICRS
- 19 Aug 2003 — FAX RECEIVED